Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-24

FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for Amitriptyline hydrochloride from Sandoz Inc under an Abbreviated New Drug Application (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amitriptyline hydrochloride (amitriptyline hydrochloride)

Snippet

SUPPL AP for AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE HYDROCHLORIDE)